NZ224086A - Biosynthetic epitope of plasmodium vivax antigen and its production - Google Patents
Biosynthetic epitope of plasmodium vivax antigen and its productionInfo
- Publication number
- NZ224086A NZ224086A NZ224086A NZ22408688A NZ224086A NZ 224086 A NZ224086 A NZ 224086A NZ 224086 A NZ224086 A NZ 224086A NZ 22408688 A NZ22408688 A NZ 22408688A NZ 224086 A NZ224086 A NZ 224086A
- Authority
- NZ
- New Zealand
- Prior art keywords
- biosynthetic
- epitope
- production
- plasmodium vivax
- vivax antigen
- Prior art date
Links
- 241000223810 Plasmodium vivax Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000001851 biosynthetic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3232687A | 1987-03-30 | 1987-03-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ224086A true NZ224086A (en) | 1991-02-26 |
Family
ID=21864341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ224086A NZ224086A (en) | 1987-03-30 | 1988-03-30 | Biosynthetic epitope of plasmodium vivax antigen and its production |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0309555A4 (en) |
| JP (1) | JPH01503514A (en) |
| AU (1) | AU617668B2 (en) |
| ES (1) | ES2009587A6 (en) |
| IL (1) | IL85905A0 (en) |
| NZ (1) | NZ224086A (en) |
| PT (2) | PT87137B (en) |
| WO (1) | WO1988007546A1 (en) |
| ZA (1) | ZA882272B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826957A (en) * | 1985-07-12 | 1989-05-02 | New York University | Immunogenic recombinant yeast expression product and method for purifying it |
| AU625713B2 (en) * | 1988-02-19 | 1992-07-16 | Microgenesys, Inc. | Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum |
| SE8904100D0 (en) * | 1989-12-05 | 1989-12-05 | Astra Ab | NEW ANALYSIS METHOD |
| NZ233255A (en) * | 1989-04-11 | 1993-02-25 | Chiron Corp | Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope |
| US5095093A (en) * | 1990-11-06 | 1992-03-10 | The United States Of America As Represented By The Secretary Of The Navy | Protective four amino acid epitope against Plasmodium vivax malaria |
| WO1993011157A1 (en) * | 1991-11-27 | 1993-06-10 | The Council Of The Queensland Institute Of Medical Research | MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4466917A (en) * | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
| US4707357A (en) * | 1984-06-26 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
| NZ213303A (en) * | 1984-09-12 | 1988-09-29 | Univ New York | Plasmodium protein, dna sequence and vaccine |
| US5700906A (en) * | 1985-07-12 | 1997-12-23 | New York University | Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein |
| US4826957A (en) * | 1985-07-12 | 1989-05-02 | New York University | Immunogenic recombinant yeast expression product and method for purifying it |
| US4693994A (en) * | 1985-11-19 | 1987-09-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Protective synthetic peptide against malaria and encoding gene |
| EP0252588A3 (en) * | 1986-05-12 | 1989-07-12 | Smithkline Beecham Corporation | Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine |
-
1988
- 1988-03-29 IL IL85905A patent/IL85905A0/en unknown
- 1988-03-30 WO PCT/US1988/001150 patent/WO1988007546A1/en not_active Application Discontinuation
- 1988-03-30 EP EP19880903724 patent/EP0309555A4/en not_active Withdrawn
- 1988-03-30 JP JP63503280A patent/JPH01503514A/en active Pending
- 1988-03-30 ZA ZA882272A patent/ZA882272B/en unknown
- 1988-03-30 AU AU15936/88A patent/AU617668B2/en not_active Ceased
- 1988-03-30 ES ES8801013A patent/ES2009587A6/en not_active Expired
- 1988-03-30 NZ NZ224086A patent/NZ224086A/en unknown
- 1988-03-30 PT PT87137A patent/PT87137B/en active IP Right Grant
- 1988-04-26 PT PT87332A patent/PT87332B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU617668B2 (en) | 1991-12-05 |
| PT87332A (en) | 1988-05-01 |
| WO1988007546A1 (en) | 1988-10-06 |
| ZA882272B (en) | 1988-09-22 |
| ES2009587A6 (en) | 1989-10-01 |
| AU1593688A (en) | 1988-11-02 |
| PT87137B (en) | 1992-07-31 |
| EP0309555A4 (en) | 1990-04-10 |
| IL85905A0 (en) | 1988-09-30 |
| JPH01503514A (en) | 1989-11-30 |
| EP0309555A1 (en) | 1989-04-05 |
| PT87137A (en) | 1988-04-01 |
| PT87332B (en) | 1992-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK104497A (en) | Method of making ornaments | |
| PH24819A (en) | Electromagnetic and method of forming same | |
| IL93763A0 (en) | Production of immobilized antibodies | |
| NZ224086A (en) | Biosynthetic epitope of plasmodium vivax antigen and its production | |
| PH21427A (en) | Malaria associated antigen and process of preparing thereof | |
| GB2176191B (en) | Antigens of plasmodium falciparum | |
| EP0435149A3 (en) | Method of producing 3-dibutyl-amino-6-methyl-7-anilinofluoran | |
| GB8802617D0 (en) | Article & method of forming same | |
| GB2220946B (en) | Method of producing free epsilon-polylysine | |
| ZA947564B (en) | Production of antigens | |
| GB2223120B (en) | Methods of forming coils | |
| ZW8386A1 (en) | Highly repetitive antigens of plasmodium falciparum | |
| ZA888983B (en) | Rhoptry antigen of plasmodium falciparum | |
| IL95825A0 (en) | Production of tetrathiocarbonates | |
| GB8905857D0 (en) | Plasmodium merozoite rhoptries antigen | |
| AU7699887A (en) | Merozoite surface antigen of plasmodium falciparum | |
| ZA856960B (en) | Antigens of plasmodium falciparum | |
| NZ221114A (en) | Merozoite surface antigen of plasmodium falciparum | |
| GR910300027T1 (en) | Production of alpha-chloro-alpha-oximino-4-hydroxy-acetophenone | |
| GB2200641B (en) | Merozoite surface antigen of plasmodium falciparum | |
| ZA875266B (en) | Merozoite surface antigen of plasmodium falciparum | |
| CS630287A1 (en) | Mouse lymphocytar hybridome producing antibodies against"core" antigen of b-hepatitis | |
| GB9102294D0 (en) | Antigen of plasmodium falciparum | |
| GB9116594D0 (en) | Production of antibodies | |
| GB9115284D0 (en) | Production of antibodies |